This Study is Designed to Evaluate PD/PK and Safety of Replagal Manufactured by Two Different Processes.
NCT01304277
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
17
Enrollment
INDUSTRY
Sponsor class
Conditions
Fabry Disease
Interventions
BIOLOGICAL:
agalsidase alfa
Sponsor
Shire